FDA approval is now being sought for the use of Monjaro for fibrosis, Dr
For example, patients who experience significant side effects with once-weekly semaglutide might tolerate once-daily liraglutide better, or vice versa
Other long-term trials designed to evaluate whether SGLT2 inhibitors have renal protective effects in participants with T2D, and without T2D but with or without chronic kidney disease and macroalbuminuria are ongoing (e.g., the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) study, NCT02065791
People forget to drink water, especially if they're also dealing with nausea
Anti-inflammatory effects of GLP-1-based therapies beyond glucose control
Its a marathon, so you need others to be on this journey with you